Key statistics
As of last trade Xencor Inc (XNCR:NMQ) traded at 24.89, -7.27% below its 52-week high of 26.84, set on Feb 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 24.18 |
---|---|
High | 24.95 |
Low | 23.92 |
Bid | 24.87 |
Offer | 24.91 |
Previous close | 24.10 |
Average volume | 846.71k |
---|---|
Shares outstanding | 69.98m |
Free float | 68.84m |
P/E (TTM) | -- |
Market cap | 1.69bn USD |
EPS (TTM) | -3.20 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 19:03 GMT.
More ▼
- Xencor Reports Third Quarter 2024 Financial Results
- Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease
- Xencor Presents Preclinical Data on XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, to be Developed for Patients with Inflammatory Bowel Diseases
- Xencor Announces Upcoming Change to Board of Directors
- Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Xencor Announces Pricing of $175 Million Public Offering of Common Stock
- Xencor Announces Proposed Public Offering of Common Stock
- Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs
- Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024
More ▼